Management of severe hypertension with nifedipine in combination with clonidine or propranolol. 1980

Y Imai, and K Abe, and Y Otsuka, and N Irokawa, and M Yasujima, and K Saito, and Y Sakurai, and S Chiba, and T Ito, and M Sato, and T Haruyama, and Y Miura, and K Yoshinaga

The hypotensive effect of nifedipine was studied in 9 patients with severe hypertension. After oral administration of 20 mg nifedipine mean arterial pressure (MAP) fell, reaching lowest values about 1 h p.a. The antihypertensive effect lasted 7 h. Treatment with nifedipine alone (80 mg/day) lowered MAP significantly on the first day, but it tended to rise again therealter. Addition of clonidine (450 micrograms/day) or propranolol (120 mg/day) enhanced the hypotensive effect. Furosemide (120 mg/day) was ineffective when added to the above described regimen. Without nifedipine the combine drugs failed to keep MAP down. The decrease of MAP observed when giving this combination of drugs was associated with a significant fall in total peripheral resistance and plasma renin activity, but did not alter cardiac output and blood volume. We concluded that nifedipine together with clonidine or propranolol is very effective in the management of severe hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155

Related Publications

Y Imai, and K Abe, and Y Otsuka, and N Irokawa, and M Yasujima, and K Saito, and Y Sakurai, and S Chiba, and T Ito, and M Sato, and T Haruyama, and Y Miura, and K Yoshinaga
January 1986, Clinical pharmacology and therapeutics,
Y Imai, and K Abe, and Y Otsuka, and N Irokawa, and M Yasujima, and K Saito, and Y Sakurai, and S Chiba, and T Ito, and M Sato, and T Haruyama, and Y Miura, and K Yoshinaga
February 1979, Annals of clinical research,
Y Imai, and K Abe, and Y Otsuka, and N Irokawa, and M Yasujima, and K Saito, and Y Sakurai, and S Chiba, and T Ito, and M Sato, and T Haruyama, and Y Miura, and K Yoshinaga
February 1979, Archives of internal medicine,
Y Imai, and K Abe, and Y Otsuka, and N Irokawa, and M Yasujima, and K Saito, and Y Sakurai, and S Chiba, and T Ito, and M Sato, and T Haruyama, and Y Miura, and K Yoshinaga
March 1987, The American journal of medicine,
Y Imai, and K Abe, and Y Otsuka, and N Irokawa, and M Yasujima, and K Saito, and Y Sakurai, and S Chiba, and T Ito, and M Sato, and T Haruyama, and Y Miura, and K Yoshinaga
August 1981, British journal of clinical pharmacology,
Y Imai, and K Abe, and Y Otsuka, and N Irokawa, and M Yasujima, and K Saito, and Y Sakurai, and S Chiba, and T Ito, and M Sato, and T Haruyama, and Y Miura, and K Yoshinaga
August 1987, Zeitschrift fur Kardiologie,
Y Imai, and K Abe, and Y Otsuka, and N Irokawa, and M Yasujima, and K Saito, and Y Sakurai, and S Chiba, and T Ito, and M Sato, and T Haruyama, and Y Miura, and K Yoshinaga
August 1980, Anesthesiology,
Y Imai, and K Abe, and Y Otsuka, and N Irokawa, and M Yasujima, and K Saito, and Y Sakurai, and S Chiba, and T Ito, and M Sato, and T Haruyama, and Y Miura, and K Yoshinaga
January 1982, Cardiologia (Rome, Italy),
Y Imai, and K Abe, and Y Otsuka, and N Irokawa, and M Yasujima, and K Saito, and Y Sakurai, and S Chiba, and T Ito, and M Sato, and T Haruyama, and Y Miura, and K Yoshinaga
January 1982, Cardiologia (Rome, Italy),
Y Imai, and K Abe, and Y Otsuka, and N Irokawa, and M Yasujima, and K Saito, and Y Sakurai, and S Chiba, and T Ito, and M Sato, and T Haruyama, and Y Miura, and K Yoshinaga
January 2016, BJOG : an international journal of obstetrics and gynaecology,
Copied contents to your clipboard!